Agilent Technologies stock holds steady as earnings beat and new analyst target support valuation
Published on 08/13/2026 at 14:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Agilent Technologies Inc. (US00846U1016) stock is trading close to its recent high after the company delivered stronger-than-expected earnings per share and double-digit revenue growth in its latest reported quarter, alongside updated guidance for fiscal 2026 as of August 12, 2026.
Earnings beat and revenue growth
Recent market data show Agilent Technologies shares changing hands at $148.28 at the regular-session close on August 12, 2026, with extended trading indicating a modest gain to $148.59 before the next day’s Wall Street open. Per the same overview, the stock’s year-to-date performance stands positive, helped by a multi-day advance that has kept the shares close to their 52-week highs.
In the latest quarterly report, Agilent Technologies posted earnings per share of $1.49 for the period ended May 27, 2026, exceeding a consensus forecast of $1.41 by $0.08. This EPS surprise of 6.43 percent points to stronger profitability than previously expected by analysts and has been a key driver for recent investor interest. Revenue for that same quarter came in at $1.83 billion, above the projected $1.80 billion and up 10 percent compared with the $1.66 billion reported a year earlier for the comparable quarter, signaling solid demand across the company’s measurement and diagnostics portfolio.
The earnings release also highlighted a net margin of 19.55 percent and a return on equity of 24.33 percent for the period ended May 27, 2026, both metrics reinforcing the company’s ability to convert top-line growth into shareholder returns. For context, earnings per share in the prior-year quarter were $1.31, so the increase to $1.49 represents an advance of $0.18 or roughly 13.7 percent, underscoring how the company has managed to expand earnings faster than revenue.
Guidance and analyst expectations
Looking ahead, Agilent Technologies has set its fiscal 2026 guidance for earnings per share in a range between $6.00 and $6.10. Within that framework, the company expects EPS of $1.48 to $1.50 in the third quarter of fiscal 2026, aligning broadly with the earnings trajectory implied by the latest results and providing a reference point for investors tracking the next set of numbers. Research analysts currently anticipate full-year EPS of $6.01, placing their view near the midpoint of management’s guidance range and suggesting that the street sees the latest quarter’s beat as sustainable.
Consensus data indicate that Agilent Technologies shares carry a rating classified as Moderate Buy, with an average price target of $160.24, implying upside potential compared with the recent close around the $148 mark as of August 12, 2026. Within that consensus landscape, one recent forecast raised the stock’s price target to $175 from $160 while maintaining a positive rating stance, a move that reflects growing confidence in the company’s fundamentals following the reported revenue acceleration and margin performance. On a percentage basis, the $160.24 average target stands around 8 percent above the $148.28 regular-session close, while the $175 target would represent a gain of more than 18 percent if achieved.
Institutional ownership data show that professional investors hold 87.41 percent of Agilent Technologies’ outstanding shares, a level that points to significant participation by long-term funds and other institutions. For retail investors, this degree of institutional involvement can signal both a strong base of fundamental holders and the potential for incremental demand if earnings and guidance continue to trend ahead of expectations. The combination of a recent EPS beat, double-digit revenue growth and supportive guidance has therefore given analysts a foundation to keep their stance constructive on the stock.
Recent price action and valuation context
Market snapshots around August 12, 2026 show Agilent Technologies stock trading at $148.27 to $148.33 during late-session and closing prints on its primary listing, with a daily decline of approximately 0.8 percent on that day following earlier gains. Over a five-day period ending August 12, 2026, the shares have advanced, contributing to a year-to-date change of 9.78 percent, which places the stock ahead of many broader health-care and life-science sector indices in performance terms. At a quoted level of $148.91 during recent trading hours, the stock remains supported by solid liquidity and relatively narrow intraday ranges.
Using the midpoint of fiscal 2026 EPS guidance at $6.05, the recent share price around $148.28 as of August 12, 2026 implies a forward price-to-earnings multiple close to 24.5 times. When compared with the $160.24 consensus price target, the same EPS assumption would translate into a multiple near 26.5 times at the target level, while the $175 forecast would equate to around 28.9 times. This valuation backdrop suggests that the market is willing to pay a premium for Agilent Technologies’ combination of measurement technologies, recurring revenue and margin profile, but also that further earnings growth will be important to justify any move toward the higher end of analyst targets.
Short-term trading data from late August 12, 2026 show extended-hours quotes of $148.27 to $148.59, a range that indicates modest post-close buying interest but no extreme volatility. Daily percentage changes of less than 1 percent during that session underscore a relatively stable tape compared with high-beta technology or biotech names. For investors, the key comparison is between the recent $148–$149 range and the consensus $160 level; the gap of roughly $11 per share is the quantified distance that would need to be bridged through either earnings upgrades or re-rating if the stock is to reach the average target.
Agilent’s measurement and diagnostics portfolio
Agilent Technologies is best known for its portfolio of analytical instruments and solutions that serve laboratories in pharmaceuticals, biotechnology, environmental testing and academic research. A representative product line is the company’s liquid chromatography and mass spectrometry systems, which are used to separate and analyze complex mixtures in applications such as drug development, food safety and clinical diagnostics. By integrating hardware, consumables and software, these systems generate recurring revenue streams and help laboratories achieve higher throughput and more accurate results, feeding directly into the revenue and margin trends reflected in the recent quarterly numbers.
The company also offers automation and informatics solutions that tie together instruments, workflows and data analysis, enabling customers to manage samples, run assays and interpret results with greater efficiency. These offerings can drive both initial capital equipment sales and ongoing service and support revenue, contributing to the 10 percent year-over-year growth in quarterly revenue reported for the period ended May 27, 2026. As demand for precision measurement and diagnostic capabilities continues to expand across life sciences and environmental markets, Agilent Technologies’ product ecosystem remains central to its ability to meet or exceed the EPS and revenue guidance it has set for fiscal 2026.
Closing stock snapshot
Agilent Technologies stock last closed the regular session at $148.28 on August 12, 2026, 3:58 p.m. ET, with after-market indications of $148.27 to $148.59 later that evening. This places the shares below the $160.24 consensus price target but supported by a recent earnings beat, 10 percent revenue growth and a fiscal 2026 EPS guidance range between $6.00 and $6.10 that anchors valuation expectations.
Company facts
Company: Agilent Technologies Inc.
ISIN: US00846U1016
Ticker: A
Exchange: NYSE
Price (as of August 12, 2026, 3:58 p.m. ET): $148.28 USD
Sector / Industry: Health care - Life sciences tools and services
Index membership: S&P 500
